Using non-hypothesized based approaches for biomarker development
Using non-hypothesized based approaches for biomarker development
Jessica Gill, PhD, RN, FAAN, Bloomberg Distinguished Professor at Johns Hopkins School of Nursing, presents research on a highly multiplexed proteomic technique that used a DNA aptamers assay to target 1,305 proteins in plasma samples from athletes with and without a sports-related concussion (SRC). Researchers identified 338 plasma proteins significantly differed in abundance in concussed athletes compared to non-concussed athletes.
Learning objectives
- Understand current limits of protein quantification
- Describe ways to improve biomarker identification and measurement related to brain injuries
- Determine ways to address current limitations to personalized medicine approaches for brain injuries
Jessica Gill, PhD, RN, FAAN
Bloomberg Distinguished Professor
Johns Hopkins School of Nursing
Jessica Gill is a national leader in research on the biological mechanisms of traumatic brain injuries (TBI). She has spent decades investigating differential responses in military personnel, athletes, and other patients that have experienced TBIs and the mechanisms underlying these divergent responses. Specifically, Dr. Gill looks for ways to use biomarkers to identify which patients are at high risk for poor recovery and long-term effects including post-traumatic stress disorder, depression, and post-concussive syndrome, and to develop treatments.
After earning her PhD at JHSON, she went to the National Institutes of Health (NIH) to complete a postdoctoral fellowship at the National Institute of Nursing Research that focused on the biological mechanisms of PTSD and depression. At NIH, she also served as a senior investigator and acting deputy scientific director of the National Institute of Nursing Research and deputy director of the Center for Neuroscience and Regenerative Medicine. Dr. Gill was the first nurse to receive the Lasker Clinical Research Scholar Award, considered the most prestigious research grant given by the NIH. As Bloomberg Distinguished Professor of Trauma Recovery Biomarkers, she will hold primary appointments in the Johns Hopkins School of Nursing and the School of Medicine, Department of Neurology.
Using non-hypothesized based approaches for biomarker development
A presentation by Jessica Gill, PhD, RN, FAAN
More webinars
WebinarMapping the human mucosal immune response to respiratory viruses
Conventionally, human immune responses have been extensively characterized using blood. Immune cells, though abundant in blood, are also found in various tissues in varying numbers and with locally relevant functional specification. Assessing immune responses in the airways over the course of infection and convalescence is critical to comprehensively mapping immunity to respiratory viral infections including influenza and SARS-CoV-2.
WebinarAccelerating precision medicine of cancer with SomaScan® proteomics
Proteomics has emerged as the next frontier in precision medicine, and several innovative proteomics platforms have been developed to drive biomarker discovery. We [at Beth Israel Deaconess Medical Center] are using the currently most comprehensive proteomics technology -- the SomaScan Platform, which measures 7,000 proteins -- to discover and independently validate diagnostic, predictive, and prognostic biomarkers for various cancers.
WebinarImproving clinical development productivity with high-plex proteomics
While the vast majority of approved pharmaceuticals target proteins, knowledge of the full complement of proteins that are acted on by drugs, or are potentially druggable, remains incomplete. Assessment of the human proteome is thus increasingly recognized as a priority for successful and cost-effective drug development and clinical research.